A Kentucky bill that would integrate the state’s medical marijuana program into its prescription drug monitoring system was approved this week by the House Health Services Committee and sent to the House Rules Committee for further consideration.
House Bill 388 makes numerous changes to Kentucky’s controlled substance statutes, but several of the most notable provisions focus specifically on how the state will monitor and regulate medicinal cannabis once dispensaries begin operating.
Under the proposal, Kentucky’s electronic monitoring system—commonly known as KASPER, which is currently used to track the prescribing and dispensing of Schedule II through V drugs—would be expanded to also track medical marijuana certifications and sales in real time. Medicinal cannabis practitioners would be required to register with the system, and dispensaries would be required to record every transaction, including how much marijuana is dispensed to each cardholder.
The system would allow dispensary agents to view cannabis sales data across licensed dispensaries in real time, while also allowing law enforcement, regulatory boards, and certain medical officials to access that information as part of investigations or oversight activities. The Cabinet for Health and Family Services would also be able to track medical marijuana from cultivation through sale to the patient.
Importantly, the bill draws a clear legal distinction between controlled substances and medical marijuana. The legislation specifies that, for purposes of prescription monitoring, “controlled substance” does not include medicinal cannabis. However, the same section of law is amended to require that the monitoring system still track cannabis certifications and dispensary activity.
In effect, the measure treats medical marijuana as something separate from opioids and other scheduled drugs under Kentucky law, while still placing it under the same statewide monitoring and diversion-control infrastructure.
House Bill 388 does not change who can qualify for medical marijuana or how patients obtain certifications, but it significantly changes how the state will oversee and track the program once retail access begins.
With approval from the House Health Services Committee, the measure now heads to the House Rules Committee, where it can be scheduled for a vote by the full House.
More articles from The Marijuana Herald:
